- Funding will enable lead candidates CTX114 and CTX203 for AMD to enter clinical trials in the next year JERSEY CITY, N.J.--(BUSINESS WIRE)--Character Biosciences, a precision medicine company ...

Field Yates of ESPN provided us with an eye-popping stat about the lack of production from the Indianapolis Colts tight end position in recent years, which we all know is a massive need this offseason ...